Session Details
[S39]Current Status and Challenges in the Development of Extracellular Vesicle-based Therapeutic Systems
Fri. Mar 28, 2025 4:45 PM - 6:15 PM JST
Fri. Mar 28, 2025 7:45 AM - 9:15 AM UTC
Fri. Mar 28, 2025 7:45 AM - 9:15 AM UTC
Room 9 (Fukuoka International Congress Center: 411 [4F])
Organizer: Makiya Nishikawa (Fac. Pharm. Sci., Tokyo Univ. Sci.), Yuki Takahashi (Grad. Sch. Pharm. Sci., Kyoto Univ.)
オーガナイザー挨拶:西川 元也(東京理大薬)
[S39-1]Development of therapeutic products based on extracellular vesicles : PMDA report
○Yoshinobu Takakura1 (1. Hakubi Center Adv. Res., Kyoto Univ.)
[S39-2]Development of Disease Therapy Using Extracellular Vesicles Derived from Mammalian Cells
○Yuki Takahashi1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ.)
[S39-3]Potent tissue protection by lipid-modified extracellular vesicles SPREDs.
○Ai Kotani1 (1. RIMD, Osaka Univ.)
[S39-4]Development of plant-derived extracellular vesicle-based therapeutic systems
○Makiya Nishikawa1, Kosuke Kusamori1, Shoko Itakura1 (1. Fac. Pharm. Sci., Tokyo Univ. Sci.)
[S39-5]Development of mesenchymal stem cell-derived extracellular vesicle preparations for practical application
○Hayato Kurata1 (1. ROHTO Pharmaceutical Co., Ltd.)
[S39-6]Regulatory science study for ensuring the quality of therapeutic EV products including exosomes and promoting their development
○Akiko Ishii-Watabe1, Hirotaka Nishimura1, Tomofumi Yamamoto1, Noritaka Hashii1 (1. NIHS)